QTRX
Quanterix CorporationNasdaqResearch view
Healthcare · Laboratory Analytical Instruments · Micro-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$145.2M
Enterprise Value$115.9M
Income$-107.2M
Sales$138.9M
Book/sh$6.25
Cash/sh$0.70
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio2.11
Current Ratio2.84
Debt/Eq0.01
EPS (ttm)$-2.51
EPS this Y-151.0%
EPS past 3/5Y—
Sales past 3/5Y9.6%
EPS Y/Y TTM-151.0%
Sales Y/Y TTM1.1%
Shs Outstand47.29M
ROA-25.6%
ROE-36.2%
ROIC-44.9%
Gross Margin46.8%
Oper. Margin-90.4%
Profit Margin-77.2%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$110.6M
2021
$105.5M
2022
$122.4M
2023
$137.4M
2024
$138.9M
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $110.6M | $105.5M | $122.4M | $137.4M | $138.9M |
| Gross Profit | $64.8M | $45.4M | $74.2M | $83.1M | $65.0M |
| Operating Income | $-56.5M | $-104.3M | $-46.0M | $-52.6M | $-125.5M |
| Net Income | $-55.5M | $-99.6M | $-28.4M | $-38.5M | $-107.2M |
| Diluted EPS | $-1.54 | $-2.69 | $-0.75 | $-1.00 | $-2.51 |
| Operating Cash Flow | $-47.6M | $-48.6M | $-18.8M | $-35.2M | $-77.2M |
| Free Cash Flow | $-61.3M | $-60.2M | $-22.7M | $-38.5M | $-79.8M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Cash-flow detail unavailable in this filing.
—
COMMUNITY · $QTRX0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Laboratory Analytical Instruments
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.